GLOBUS MEDICAL INC GMED
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
6/9
Piotroski F — financial health
10.06
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $2.9B | $537.9M | — | $588.8M | $4.6B |
| 2024 | $2.5B | $103.0M | — | $405.2M | $4.2B |
| 2023 | $1.6B | $122.9M | $1.0B | $165.2M | $4.0B |
| 2022 | $1.0B | $190.2M | $759.1M | $104.4M | $1.8B |
| 2021 | $958.1M | $149.2M | $718.9M | $219.4M | $1.7B |
| 2020 | $789.0M | $102.3M | $571.6M | $135.1M | $1.5B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Davidar David D | director | 2026-06-05 | Option exercise | 25,000 | $26.27 |
| Davidar David D | director | 2026-06-05 | Sell | 25,000 | $80.76 |
| RHOADS ANN D | director | 2026-06-04 | Option exercise | 25,000 | $26.27 |
| Huller Kelly | EVP, GC, Corporate Secretary | 2026-02-25 | Option exercise | 20,000 | $43.58 |
| Huller Kelly | EVP, GC, Corporate Secretary | 2026-02-25 | Sell | 20,000 | $94.50 |
| Huller Kelly | EVP, GC, Corporate Secretary | 2026-02-12 | Option exercise | 10,000 | $45.64 |
| Huller Kelly | EVP, GC, Corporate Secretary | 2026-02-12 | Sell | 10,000 | $87.67 |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 10.06 (safe)
- Working capital / assets 0.307
- Retained earnings / assets 0.262
- EBIT / assets 0.09
- Equity / liabilities 6.269
Source: SEC EDGAR filings · CIK 0001237831 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.